Archive for A2 Milk

The A2 Advantage: A Producer’s Guide to Premiums, Genetics, and the Carbon Connection

Everyone says A2’s just hype. Tell that to farmers banking 100% premiums on milk yield.

EXECUTIVE SUMMARY: Look, I’ve been watching this A2 thing for years, and here’s what changed my mind – the premium isn’t going anywhere, and the science finally backs it up. We’re talking 50-100% premiums that are holding steady even with everything else falling apart in commodity markets. China’s A2 segment jumped 14% just in the first half of 2025, now claiming 20% of their infant formula market value… that’s real structural demand, not some health fad.The kicker? Most Holstein herds are already testing 50-60% A2 genetics – you might be sitting on premium milk and selling it commodity. At $25-40 per head for genomic testing, you’re looking at potentially discovering a revenue stream that California producers are already riding to $8-9 per gallon. With USDA operating loans at 5.000% and consumer premiums this strong, this isn’t about chasing trends anymore – it’s about capturing value that’s already there.

KEY TAKEAWAYS

  • Test your genetics first – Most Holstein herds hit 50-60% A2 genetics naturally; at $25-40/head testing costs versus 50-100% milk premiums, your ROI calculation is simple math that works in today’s tight margin environment.
  • Start with segregation strategy – Wisconsin’s MilkHaus Dairy is processing just 100 of their 360 cows separately for A2 cheese production, proving you don’t need full herd conversion to tap premium markets in 2025.
  • Stack the sustainability angle – Traditional A2 breeds like Jerseys show better feed efficiency, positioning farms for both A2 premiums and emerging carbon credit programs as USDA pilots recognize breed efficiency metrics.
  • Build direct-to-consumer channels – Vermont Jersey operations are pulling premium pricing on A2 raw milk and aged cheeses to Boston markets, while California organic A2 hits $8-9/gallon – direct sales bypass commodity pricing entirely.
  • Time your conversion with financing – At current 5.000% USDA operating rates, conversion financing is more accessible than it’s been in years, but processing capacity for segregated A2 milk is tightening across regions.
 A2 milk, genomic testing, dairy profitability, premium milk markets, dairy breeding strategy

You know what caught my attention at the last World Dairy Expo? Three different producers – completely unrelated, from Wisconsin to New Zealand – all mentioned they’re testing their herds for A2 genetics. That’s when you know something has shifted from a trend to a serious business opportunity.

If there’s one topic dominating dairy discussions lately, it’s A2 milk. What started as a niche health trend has evolved into something that’s genuinely transforming our perspective on premium positioning. With conventional milk struggling in commodity markets and consumers willing to pay 50-100% premiums for A2 products, this is no longer just marketing hype.

A2 milk is projected to become a $7.62 billion global market by 2034. That’s not wishful thinking from market researchers – that’s real money flowing through real supply chains, and it’s becoming clear that dismissing this as just another fad would be a serious mistake.

Your A2 Quick Reference Guide

Market Reality Check: Global A2 market projected to exceed $7.6B by 2034, with consumer premiums holding steady at 50-100% over conventional milk

Science Getting Clearer: While cognitive claims remain weak, peer-reviewed studies now confirm digestive benefits linked to gut microbiota changes

Strategy is Everything: Success depends on genetic testing, long-term breeding strategy, and – this is crucial – securing access to segregated processing

Start Local First: Evaluate your regional processors and direct-to-consumer opportunities before making major investments

The Numbers That Actually Matter

What strikes me about these market projections is how they’re playing out in real time. China’s A2 market tells the story perfectly:

China’s A2 protein segment grew 14% in just the first half of 2025 and now accounts for 20% of their total infant formula market value. When discussing a competitive market, capturing one-fifth of the total value isn’t just a matter of consumer preference – that’s structural demand.

The premium positioning is holding too. Even with all the economic uncertainty we’ve been dealing with, consumers are still paying premiums of 50-100% over conventional milk. That’s exactly the kind of value-added positioning we’ve been discussing as needed in this industry for years.

Here’s what’s fascinating, though – many A2 buyers don’t even have digestive issues with regular milk. They’re paying more because they believe it’s better milk. This represents exactly the kind of premium positioning that can actually stick.

What’s Actually Happening in Science

The biochemistry behind A2 milk is legitimate, even if some of the health claims can be somewhat exaggerated. When you’re dealing with conventional milk – the A1 beta-casein variety that most of our Holsteins produce – digestion releases this peptide called beta-casomorphin-7 (BCM-7).

Here’s where it gets interesting: research shows this peptide can actually cross the blood-brain barrier and interact with opioid receptors in our central nervous system. While this biochemical interaction is confirmed, it’s crucial to note that large-scale human studies haven’t substantiated the marketing claims linking it to conditions like autism or cognitive decline.

That’s not small stuff when you think about it. We’re talking about a food component that can literally reach the brain.

Now, before anyone gets carried away, most of the cognitive claims you see splashed across A2 marketing materials are still pretty thin on human clinical trials. But the digestive benefits? Those are starting to look solid.

What strikes me about recent work published in PLOS ONE is how concrete the results were. Two weeks of A2 milk consumption led to significant changes in gut microbiota – we’re talking about increases in beneficial bacteria like Bifidobacterium longum and Blautia wexlerae. These aren’t just random microbes; they’re directly linked to better nutrient processing and reduced gut inflammation.

Participants who typically experienced digestive discomfort with regular milk showed notable improvements with A2 milk consumption. From a market positioning standpoint, this is compelling stuff – actual functional benefits you can point to.

The Genetic Reality Check

Here’s where breed choice really matters in this whole A2 conversation. Most producers I talk to are surprised when they learn where their herds actually stand genetically.

According to recent work from Dr. John Lucey at the University of Wisconsin’s Center for Dairy Research, “Most U.S. Holsteins produce a mixture of the two, often a 50-50 or 60-40 split, depending on where the genetic lines came from. Guernsey, Jersey, and Brown Swiss tend to produce mostly A2.”

That breed difference alone changes your whole timeline and strategy. If you’re running Holsteins, you’re starting from a different place than someone with a Jersey herd. It’s not just about the genetics – it’s about understanding what you’re working with.

The testing itself costs around $25-40 per animal to determine your current status. That’s not nothing when you’re talking about a 300-cow herd, but it’s the kind of investment that makes sense when you’re looking at those premium opportunities.

What’s particularly noteworthy is how this plays out across different regions. In the Upper Midwest, I’m seeing Holstein herds that test surprisingly high for A2 genetics – sometimes 60-70% – likely due to specific breeding lines that came through certain AI companies. Meanwhile, down in the Southeast, some Jersey herds are testing lower than expected, which suggests there’s more A1 genetics circulating in those bloodlines than people realize.

The Next Frontier: Connecting A2 to Carbon and Policy

Here’s something that’s flying under the radar but shouldn’t be – the intersection of A2 genetics and sustainability is creating a potential triple-win scenario that smart producers are already positioning for.

Traditional A2 breeds, such as Jerseys and Guernseys, often have better feed conversion rates, which translates to lower methane production per pound of milk. With carbon pricing becoming a reality through programs like California’s LCFS expansion and the EU’s Green Deal, which is pushing sustainability metrics, a double premium opportunity may be emerging.

The new USDA carbon credit pilot programs are starting to recognize these breed efficiencies. Operations that can document both A2 genetics and improved feed efficiency might qualify for additional incentives by 2026. Initial word from extension specialists suggests that farms documenting both A2 genetics and carbon efficiency could receive stacked premiums.

I’ve been hearing from processors in the Northeast who are starting to ask about both A2 genetics and carbon footprint data. That’s a trend that’s expected to accelerate, especially as more retailers make sustainability commitments. With the EU’s Green Deal pushing sustainability metrics and New Zealand implementing their emissions pricing scheme, there’s a real question about positioning A2 milk within these new frameworks.

The methane credit angle is particularly interesting. Some of the same breeds that naturally produce more A2 milk also tend to be more efficient feed converters, lower methane per pound of milk. As carbon pricing becomes more of a reality (and it’s coming, whether we like it or not), we’re looking at a potential convergence where A2 genetics, carbon efficiency, and premium positioning all align.

The Conversion Challenge – What It Actually Takes

Converting to A2 production is a significant operational commitment, not as simple as flipping a switch. Here’s what you’re really looking at:

Investment Reality: The real cost is time and a multi-generational breeding strategy. From industry observations, you’re looking at several generations to achieve high A2A2 frequencies – the exact timeline depends heavily on your starting genetics and breed composition.

Processing Bottleneck: Access to segregated processing facilities is, in fact, the biggest challenge. I’ve talked to producers with beautiful A2 herds who ended up stuck selling into commodity markets because they couldn’t secure premium outlets.

Financing Actually Looks Good: Current USDA Farm Service Agency operating loans are running at 5.000% as of July 2025, which makes conversion financing accessible for qualified operations. That’s more reasonable than the higher rates we saw a couple of years back.

Here’s the thing, though – and this is where I see producers getting tripped up – you can’t just think about the genetics. The infrastructure piece is massive. You need separate tanks, separate trucks, and separate processing lines… or, at the very least, processing partners who can handle the segregation requirements.

Real Operations Making It Work

What’s working? Direct-to-consumer operations are absolutely crushing it. Let me tell you about operations that are getting it right across different regions:

MilkHaus Dairy in Fennimore, Wisconsin, is testing about 100 of their 360-head Holstein herd for A2 genetics. They’re housing those A2 cows separately, keeping the milk completely segregated, and processing it into cheese at local plants. Now they’re selling 12 different cheese flavors nationwide through their online store. The genius part? They’re not trying to convert their whole herd – they’re just maximizing the value of what they’ve got.

Two Guernsey Girls Creamery in Freedom, Wisconsin, took a different approach. They broke ground on a small bottling and cheese-making facility in late 2020, opened it in summer 2021, and now process all their milk on-site. Pasteurized white milk, chocolate milk, cheese curds – all A2, all local, all profitable. What started as a 4-H project has grown into a thriving farmstead operation.

But it’s not just Wisconsin. In California, I’ve been hearing from producers in the Central Valley who are pairing A2 genetics with organic certification – apparently, this combination is hitting a sweet spot with Bay Area consumers, who are willing to pay serious premiums. “We’re seeing $8-9 per gallon for A2 organic,” one Fresno County producer told me last month. “That’s game-changing money.”

Meanwhile, in Vermont, there’s a Jersey operation that has gone full A2 and direct-to-consumer. They’re selling A2 raw milk permits and A2 aged cheeses to the Boston market – completely different approach than what we’re seeing in the Midwest, but it’s working for their customer base.

The key here – and this is what I keep telling producers – is understanding that success often depends more on market positioning and consumer education than just having the genetics. These operations work directly with consumers, educating them about the differences and building brand loyalty.

Regional Patterns That Are Actually Emerging

The A2 opportunity isn’t uniform across regions, and that’s something you really need to factor into your planning. What works in Wisconsin might not work in California, and what sells in Australia definitely won’t automatically work in Iowa.

Here’s what I’m seeing in different regions: Upper Midwest operations with established local markets are doing well with direct sales. The cheese culture up there really helps – consumers understand premium dairy products. West Coast producers are finding success pairing A2 with organic certification to tap into that California wellness market.

However, what’s interesting is that I’m hearing from Northeast producers who are struggling with the infrastructure piece more than expected. Processing capacity for segregated A2 milk is tighter than anticipated, especially in Vermont and New York. One producer in the Hudson Valley told me they’re trucking A2 milk three hours to find a processor who can handle the segregation requirements.

Southeast operations? They’re dealing with entirely different challenges. The consumer demand is there, but the genetic starting point is often lower than expected. Heat stress is also affecting A2 conversion timelines in ways that Northern operations don’t have to consider.

What’s fascinating is how weather patterns are also affecting this. The drought conditions we’ve been seeing in parts of the West are actually pushing some producers toward A2 conversion because they’re already having to make genetic decisions about their herds – might as well optimize for premiums while you’re at it.

What This Means for Your Operation

The cognitive benefits everyone’s talking about? The science isn’t there yet. However, the market opportunity is real, and consumer willingness to pay premiums remains strong, even amid the ongoing economic challenges.

If you’re considering A2 conversion, start with genetic testing to understand your baseline. Don’t rush into wholesale changes – gradual conversion through selective breeding spreads your investment while you build market relationships. The sweet spot seems to be operations over 200 cows, where you can absorb conversion costs across larger production volumes.

Here’s what I’d recommend: evaluate your local market access first. Do you have processing facilities that can maintain A2 segregation? Are there premium retailers interested in carrying your product? Can you build direct-to-consumer channels?

But honestly? The most important thing is to be realistic about timelines. This isn’t a quick pivot. If you’re serious about A2, you’re looking at a long-term strategy – breeding decisions today based on where you think the market will be in 2030.

And here’s something else to consider… the regulatory landscape is shifting. With sustainability requirements tightening and carbon accounting becoming more standard, A2 genetics might end up being just one piece of a broader premium positioning strategy. The producers who are thinking ahead are already connecting A2 to metrics for feed efficiency, methane reduction, and soil health.

The Bottom Line

The combination of documented gut health benefits, resilient premium pricing, and developing infrastructure creates a compelling and tangible opportunity. What’s particularly exciting is how this aligns with the broader sustainability conversation. We’re potentially looking at a convergence where A2 genetics, carbon efficiency, and premium positioning all intersect.

This isn’t about jumping on the latest trend – it’s about positioning your operation for long-term success in an evolving premium dairy market. The question isn’t whether A2 milk will succeed – it’s whether you’re positioned to capture your share of this expanding opportunity.

The producers who are succeeding aren’t just chasing the A2 premium – they’re building integrated strategies that position them for whatever comes next. That’s the real lesson here.

Complete references and supporting documentation are available upon request by contacting the editorial team at editor@thebullvine.com.

Learn More:

Join the Revolution!

Join over 30,000 successful dairy professionals who rely on Bullvine Weekly for their competitive edge. Delivered directly to your inbox each week, our exclusive industry insights help you make smarter decisions while saving precious hours every week. Never miss critical updates on milk production trends, breakthrough technologies, and profit-boosting strategies that top producers are already implementing. Subscribe now to transform your dairy operation’s efficiency and profitability—your future success is just one click away.

NewsSubscribe
First
Last
Consent

Synlait and a2 Milk Settle Infant Formula Showdown

Find out how Synlait and a2 Milk settled their infant formula dispute. What are the implications for dairy farmers and milk production? Read on.

Summary: The recent resolution between Synlait and a2 Milk has significant implications for the dairy industry, especially in infant formula manufacturing. With Synlait’s exclusive rights ending by January 2025, the production landscape might change, impacting market dynamics and corporate strategies. Despite this, Synlait will keep essential regulatory registrations and some priority arrangements with a2 Milk. Investors are optimistic, as seen in rising share prices for both companies, reflecting renewed confidence in their future.

  • Synlait Milk and a2 Milk have settled disputes over exclusive manufacturing rights.
  • Synlait’s exclusive manufacturing rights for a2 Milk’s infant formula will end on January 1, 2025.
  • Synlait will continue holding critical regulatory registrations and maintaining priority arrangements with a2 Milk.
  • Investor confidence is high, as evidenced by the rise in share prices for both Synlait and a2 Milk.
  • a2 Milk will make a one-off payment of NZ$24.75 million to Synlait as part of the settlement.
  • The settlement is conditional on Synlait’s successful equity raise and refinancing of its banking facilities.
agreement, New Zealand, Synlait Milk, shareholder, a2 Milk, manufacturing rights, newborn formula products, concerns, dairy industry, intricacies, dispute, exclusive manufacturing rights, baby formula, long-term agreement, production, cancelation notifications, contract's legality, Synlait, warnings, settlement, advantages, Chinese regulatory State Administration for Market Regulation (SAMR) registration, Dunsandel facilities, price issues, one-time payment, equity raising, refinancing, banking facilities, ceasefire, stabilizing, corporations, market reaction, Synlait shares, investor confidence, a2 Milk, stakeholders, financially, Future, completion, prerequisites, uncertain situation, watershed moment, economic relationship, dairy sector dynamics, Chinese regulatory registration, production levels, share price increases, outcome

Have you ever wondered what happens when two dairy titans collide? The recent agreement between New Zealand’s Synlait Milk and its shareholder a2 Milk for manufacturing rights for newborn formula products gives an intriguing peek into the dairy industry’s intricacies. With Synlait shares up 16.7% and a2 Milk up 0.8%, this story is more than milk foaming up. But what exactly does this deal entail for dairy farmers and the industry? Let’s get into the specifics.

When Dairy Titans Disagree: Inside the Synlait and a2 Milk Manufacturing Rights Battle

The argument between Synlait and a2 Milk revolves around a2 Milk’s exclusive manufacturing rights to baby formula. Initially, these rights were protected by a long-term agreement to increase the production of certain items. However, problems escalated when a2 Milk sent cancelation notifications in September, challenging the contract’s legality after more than seven years. Synlait acknowledged the warnings, stating that its exclusive manufacturing rights will end on January 1, 2025.

A Carefully Negotiated Truce: What the Synlait and a2 Milk Settlement Means for the Future

The present settlement contributes considerably to the problematic connection between Synlait Milk and a2 Milk. Synlait confirmed the legitimacy of a2 Milk’s cancellation notifications, which is fundamental to the settlement. This acknowledgment is significant because Synlait’s exclusive manufacturing rights for phases 1 through 3 of a2 Milk’s newborn formula expire on January 1, 2025.

Despite this, the deal provides certain advantages for Synlait. The firm maintains its Chinese regulatory State Administration for Market Regulation (SAMR) registration, which is required for production at its Dunsandel facilities. Meanwhile, a2 Milk has agreed to settle many price issues and make a one-time payment of NZ$24.75 million to Synlait.

However, Synlait’s portion of the arrangement is contingent on completing its equity raising and refinancing its banking facilities, for which a2 Milk has offered assistance. This elaborately knit deal looks to be a carefully negotiated ceasefire aimed at stabilizing the destinies of both corporations.

The Market Reacts: Investor Confidence Soars Despite Initial Concerns

While the corporate drama between Synlait and a2 Milk first raised investor concerns, the market’s reaction to the resolution speaks volumes. Synlait shares soared 16.7% to NZ$0.35, their highest level in a month, indicating significant investor confidence in the company’s future despite losing exclusive rights (Reuters). Conversely, a2 Milk saw a slight 0.8% increase to NZ$7.48, showing cautious confidence among its stakeholders. This tiny uptick implies that investors appreciate the agreement but are concerned about its long-term repercussions.

Financial Strings Attached: The Price of Synlait’s New Reality 

The settlement between Synlait and a2 Milk has significant repercussions. As part of the settlement, a2 Milk agreed to make a one-time payment of NZ$24.75 million ($14.81 million) to Synlait. While Synlait will no longer have exclusive rights to produce and supply stages 1 through 3 of a2 Milk’s newborn milk formula products beginning January 1, 2025, it is still subject to specific ongoing commitments. These include obtaining a minimum yearly amount of goods and maintaining special priority arrangements for a2 Milk. Furthermore, Synlait maintains the Chinese regulatory State Administration for Market Regulation (SAMR) registration required for its Dunsandel manufacturing operations.

Regulatory Compliance Continues to Play a Crucial Role in This Industry 

Regulatory compliance is essential in this business. Synlait’s holding of the Chinese State Administration for Market Regulation (SAMR) registration for its Dunsandel production facilities remains critical. This registration is required for any firm looking to enter the lucrative Chinese baby formula market, making it a key component of Synlait’s strategic assets.

Financially, the deal is anything from clear. Synlait’s future depends on completing its equity raising and refinancing its banking facilities. The fact that a2 Milk has agreed to support these efforts suggests a complicated financial interaction. This support is critical to Synlait’s liquidity and reputation with investors and banks. If these economic prerequisites are not satisfied, the settlement may fail, returning both parties to an uncertain situation.

The Bottom Line

The settlement between Synlait and a2 Milk represents a watershed moment in their economic relationship, potentially ushering in new dairy sector dynamics. Despite losing its exclusive manufacturing rights, Synlait maintains critical Chinese regulatory registration, allowing it to maintain significant production levels for a2 Milk.

Financially, the one-time payment and the terms attached to Synlait’s refinancing complicate matters, revealing the deep links between corporate discussions and market responses. Indeed, the share price increases for both firms demonstrate investor confidence in this outcome.

For dairy producers, this settlement may indicate a change in the industry’s power balance and the structure of competitive coalitions. Could this spark more collaborative or competitive partnerships among industrial titans? What does this imply for smaller market players?

Learn more: 

12 Things You Need to Know About A2 Milk

When a new food trend presents itself a considerable amount of the success or failure in consumer uptake relates back to the way the product was introduced to the marketplace.  Drinking milk is by no means a “new” marketing trend but with the acknowledged trend toward healthier eating and better diet choices, the entry into the marketplace of a “new and better” milk drink is making ripples in milk glasses around the world. Milk has certainly seen its share of positive and negative marketing.  Everyone relates to and has positive feelings about the “milk moustache” campaign.  But mothers worldwide deal with the issues of “lactose intolerance” and “mother’s milk versus cow’s milk”. Every dairy producer faces the arguments of natural, unnatural or pasteurized.  And even with the acceptance or more flavored milks, the health issues have not been truly answered. What does this “new” milk mean to dairy producers?

Something Exceptional? Or Exceptional Marketing?

An Australia based firm – A2 Corp. – has been selling a brand of A2 milk in New Zealand and Australia for the past 10 years and is poised to launch into the North American market. Their growing body of research suggests that A2 milk may provide the answer for the 1 in 4 Americans who suffer from lactose intolerance.  The A2 Company hypothesizes that the problem is that they are unable to digest A1, a protein most often found in milk from high producing Holstein Cows. They propose that the A2 protein which predominates in milk from Jersey, Guernsey and most Asian and African cow breeds is more easily digested.

It’s about Leaky Gut Syndrome.

As with many health food trends, evidence shows they often get the first foot hold in the alternative medicine field.  From that perspective, the leading explanation for why some people can’t tolerate A1 milk is attributed to leaky gut syndrome. The idea that loose connections in the gut, “like tears in a coffee filter, allows proteins to enter the body and run wild.  In response the body sends immune cells to fight the autoimmune invaders and the result is swelling and pain from the resulting inflammation.  These symptoms are associated with arthritis, diabetes and autism.

What’s wrong with A1?

The real fiend in A1 milk according to A2 proponents is that, when digested, A1 beta-casein releases beta-casomorphin7 (BCM7), an oploid with a morphine-like structure.  Numerous recent tests report higher-than-average levels of BCM7 in blood from people with autism and schizophrenia. Furthermore, a recent study that is currently under review in the Journal of Nutritional Biochemistry reports on cell cultures research by Richard Deth and Malav Trivedi, both in the Pharmacology Department at  Northeastern University in Boston, that shows similar high amounts of BCM7 in gut cells causes a chain reaction that creates a shortage of antioxidants in neural cells.  This is a condition that other research has tied to autism.

Where’s the SCIENCE?

As for leaky gut, this is a condition that many adults may suffer from.  However, the condition is normal in babies under a year of age, who naturally have semi-permeable intestines.  Therefore, when they’re fed typical cow-milk formula, problems arise with digestion.  “A 2009 study documented that formula-fed infants developed muscle tone and psychomotor skills more slowly than infants that were fed A2-only breast milk.  Researchers in Russia, Poland and the Czech Republic have suggested links between BCM7 in cow milk and childhood health issues.  Another more recent study implicates BCM7 in sudden infant death syndrome, reporting that some “near-miss SIDS” infants had blood serum containing more BCM7 than the blood of healthy infants of the same age.” Research is ongoing to support these claims.

Partners on the Frontier

Bob Elliott, Professor of Child Health Research at the University of Auckland opened up discussions about A1 milk and diabetes in Samoan Children.  In a 1997 study published by the International Dairy Federation, Elliott showed A1 beta-casein caused mice to develop diabetes. In 2000 he partnered with entrepreneur Howard Paterson, then regarded as the wealthiest man on New Zealand’s South Island, to found the A2 Corporation.

False and Misleading?

Those charged with responsibility for public health and safety are feeling the pressure from this new product. In 2009 the European Food Safety Authority reported that they found no link between consumption of A1 milk and health and digestive problems.  To date, much of the supporting research has come from the A2 Corp., which holds a patent for the only genetic test that can separate A1 from A2 cows. Some fear a conflict of interest arises here.  In 2004, the same year that A2 Corp. went public on the New Zealand Stock Exchange, Australia’s Queensland Health Department fined A2 marketers $15,000 for making false and misleading claims about the health benefits of its milk and, at least for New Zealand’s Food Safety Minister, the debate was resolved.

The Door is Open to Welcome New Milk

Debate over or not, the A2 Corporation moved forward to market its a2 brand milk in New Zealand and Australia, where its currently accounts for about 8 percent of dairy product sales Down Under. In 2012, A2 expanded distribution through the Tesco chain into Great Britain. Currently a two-liter bottle sells at an 18 percent premium over conventional milk. Building on consumer acceptance in these locations, A2 is poised to re-launch into the U.S. market where they feel, unlike on their previous entry, there are now enough American consumers willing to pay a premium for A2 milk. The good news appears to be that A1 is not the causative agent for diabetes, heart disease and cancer.

Ready for Research

In building the A2 hypothesis, it becomes necessary to compare its benefits to the problems of A1 milk. In 1993 Elliott proposed that consumption of A1 milk could account for the unusually high incidence of type-1 diabetes among Samoan children growing up in New Zealand.  A colleague, Corran McLaclan, later found strong correlations between per capita consumption of A2 milk and the prevalence of diabetes and heart disease in 20 countries.  Critics explain the relationships away by other  factors such as diet, lifestyle and exposure to Vitamin D as suggested by research published by  Elliott  and  in the book written by Keith Woodford,(Devil in the Milk: Illness, Health and the Politics of A1 and A2 Milk.). The time is ripe for responsible research to resolve these issues.

Coming to A Grocery Store Near You

A2 Corporation is understandably cautious about suggesting that consuming its products is a solution to preventing serious diseases.  Their marketing emphasizes instead the digestive benefits of its fluid milk, fresh cream and infant formula products. Regardless of your current position in this “Battle of the Milks”, when it comes to the health of the next generation, we all need to take a stand. Worldwide A2 Corporation is into several years of expansion into the UK, Ireland and China.

A2 From the Farm to the Table

Along with being exposed to new dairy products, today’s consumer wants verification for what they are being sold. A2 Corp. explains that the company’s farmer-suppliers use DNA analysis of tail hair from each cow to certify she is producing A2 milk, which is kept segregated through processing.  They also report that it is now possible to convert a herd of A1-producing cows to A2- producing cows. They are working with selected dairies that are making this conversion and test-marketing A2 milk in a number of U.S. states.

A1, A2 and AI

AI companies are well aware of the A1/A2 debate and are taking steps to stay up on new developments.  Many US and Canadian AI companies keep records of the A1/A2 genetics of their genetic offerings. The development of A2 producing Holsteins is gaining momentum and breeders with long term vision are phasing out A1 cows and are confident they can maintain high production throughout the transition. At the leading edge are those who seek niche markets using the A2 dominant breeds such as Jersey, Guernsey and Normande.

The Bullvine Bottom Line

As with any other health claim, there will be early adopters and those who wait until the facts are all in.  I can’t help but ask, “When was the last time, you were absolutely certain of the nutritional science behind all the food you eat?”  Having said that, it isn’t difficult to accept the proposition that there are certain people in the population, particularly babies, who react severely to the A1 protein.  Four fifths of our family can dine delightfully on shellfish without incident.  Our baby risks anaphylactic shock from merely sniffing some on a buffet. So back to A1 and A2.  Is the market big enough for both?  Is one right?  The other one wrong?  The spotlight is on milk in a positive way. Sometimes we spend so much time defending the tradition that we miss the opportunity of bringing a whole new consumer into the dairy aisle.

 

 

Get original “Bullvine” content sent straight to your email inbox for free.

 

 

[related-posts-thumbnails]

“Got Milk” is becoming “Got More”

“Drink your milk.”  Dairy farmers aren’t the only ones who have been raised with this mantra and its follow-up don’t-argue-with-me reasoning, “It’s good for you!”  There are many parenting proverbs that haven’t stood the test of time. but milk`s goodness has.

Milk has Already Got More Good Stuff

There is significant recent scientific research to prove that milk contains several disease- fighting compounds. Research is also evaluating the potential health benefits of proteins that are found in milk.

Cows are Putting More Good Stuff Into the Milk

With the proof of milks’ already healthy properties, comes the good news that scientists have learned that these properties can be increased by feeding cows specialized diets. The potential is definitely here for dairy farmers to change the way they feed their cows and thereby raise the health-enhancing properties of milk.

For example, in a recent study, Oregon State researchers were able to increase the level of omega-3 fatty acids in milk.  They also were able to decrease the amount of saturated fat.  Both these results came through feeding flaxseed to cows. This is great news for consumer health.  Less cholesterol and more omega-3 fatty acids in our human diet reduces the risk of heart disease.

What More Has Milk Got for Me?

Research trials have shown that consuming butter with elevated levels of CLA can reduce the size of cancerous tumors. CLA is Conjugated Linoleic Acid and is a naturally occurring anti-carcinogen. Researchers at several universities, including Cornell. have discovered they can increase the level of cis-9 trans-all CLA by feeding cows certain nutrients.

Other news from this area reports that a2 brand milk comes from cows specially selected to produce A2 beta-casein protein rather than A1. Most cow milk contains both types of beta-casein protein – A2 and A1. The A1 beta-casein protein has been linked with digestion and health issues so having more A2 is a plus.

A2 Corporation, the manufacturer of a2 brand milk products, targets three areas of growth: building its beverage business in Australia and New Zealand, capturing niche shares of global milk and dairy product markets and developing an infant formula business with an initial focus on China.  In April 2012, they announced a strategic agreement with Synlait Milk Limited in New Zealand to manufacture a2 brand nutritional powders, including milk powders and infant formulas for A2C.  According to A2C managing director Geoffrey Babidge, the a2 brand’s growing credibility will provide a platform for the firm’s expansion plans in the UK, Ireland and China. In December 2012 production of the China-destined a2 branded infant formula was set to begin.

Milk has Got to Have More Taste!

When a food has earned the label “good for us”, we sometimes choose not to eat or drink it claiming it doesn’t register on our taste scale.  Since the 1970s milk consumption has been declining and certainly consumer taste preferences are part of that statistic.  In the U.S. the volume of total liquid dairy is declining. Consumption of white milk is forecast to decline by 6.5% between 2011 and 2015.  But then comes the “good taste” news.  Consumption of flavored milk is growing and expected to increase to 9.5% by 2015. Flavored milk, the second most widely consumed Liquid Dairy Product (LDP) after white milk, is forecast to increase globally by a compound annual growth rate (CAGR) of 4.1% between 2012 and 2015, rising from 17.0 billion liters to 19.2 billion liters.

The World Wants More Flavors

In the past five years, 2009 to 2013, four emerging countries – Brazil, China, India and Indonesia – are driving the increased demand for flavored milk. While developing countries accounted for 66% of flavored milk consumption, this is forecast to rise to 69% by 2015.

Research shows that China, South Asia and Southeast Asia drink more than half the world`s flavored milk. In fact, just six Asian countries – China, India, Indonesia, Malaysia, the Philippines and Thailand – consume 47% of the world`s flavored milk.  This highlights that emerging economies are the growth engines of the dairy industry.

North America`s Got Apple Pie Milk and More

While not leading the consumption of flavored milk, North America is certainly not out of this tasteful picture.  Just in time for birthday celebrations on Independence Day Shatto Milk Co. of Osborn, Mo., stocked store shelves with apple pie-flavored milk to celebrate its own 10th anniversary.  Other flavors this flavorful company produces include cherry chocolate and mint chocolate milk. According to Dennis Jonsson, President and CEO of Tetra Pak Group “For consumers unwilling to compromise on taste, health or convenience, flavored milk is proving to be an increasingly popular alternative to other beverages.”

Flavored Milk’s Got More with Less Packaging

Cartons have become the established packaging format for flavored milk, according to Tetra Pak.  They accounted for 62% RTD (ready to drink) flavored milk packaging in 2012, up from 57% in 2009, and are expected to rise to above 64% in 2015. Portion packs are expected to reach 81% of RTD flavored milk consumption.

Milk’s Got More Added Value

Whether you`re attracted to milk for its high nutrition, health benefits or good taste, milk products today can meet a huge range of  needs.  It starts with the desire for nutritious and healthy food.  Developing countries are turning to nutrient-rich milk products.  In prosperous urbanized areas of the world the fast pace of modern life demands tasty, flavored milk in convenient packaging. Consumers are eager to try new and unusual food and drinks. New varieties of milk products will most definitely increase milk consumption.  Additionally, these “designer” dairy products could sell for premium prices.

The Bullvine Bottom Line

Kudos to dairy producers, the scientific community and marketing wizards.  The production of milk with so many “Got-More” features means we are improving the health of the consumer and the health of the dairy industry simultaneously! Now that’s more like it!  So “Drink your milk!  It’s good for you!”

Get original “Bullvine” content sent straight to your email inbox for free.

 

[related-posts-thumbnails]

Send this to a friend